Skin Cancer Treatment Reimagined
Now there is a non-invasive treatment option for non-melanoma skin cancer. OncoPatch improves patient experience by using low-energy beta therapy. Get back to living with OncoPatch.
OncoPatch is applied directly to the lesion in a doctor’s office. It uses low-energy beta therapy and requires as little as one treatment to be effective.
How OncoPatch Works
OncoPatch provides an effective, non-invasive treatment for non-melanoma skin cancers, including basal and squamous cell carcinomas. OncoPatch uses low-energy beta therapy applied directly to the lesion. This type of therapy has a shallow penetration range, sparing the healthy tissue adjacent to the cancer and allowing for effective treatment with less pain and fewer side effects.
OncoPatch can be administered by a physician and requires as little as one office visit to be effective.
Clinical studies of low-energy beta therapy have demonstrated cure rates comparable to more invasive treatment options for non-melanoma skin cancer. Clinical studies of OncoPatch are ongoing.
Safe & Effective
Easy to Administer
Patient Convenience
Spares Healthy Tissue
Transforming Non-Melanoma Skin Cancer Treatment
OncoPatch is ideal for cosmetically-sensitive and non-surgical candidates seeking effective treatment for non-melanoma skin cancer.
High Cure Rates*
OncoPatch is expected to offer cure rates comparable to more invasive treatment options. *Clinical trial ongoing.
Better Patient Experience
OncoPatch treatment is non-invasive and requires as little as one application to be effective.
Fewer Complication Risks
Compared to surgery, low-energy beta therapy allows for targeted treatment with little collateral damage and no reconstruction needed.
Increased Revenue
Clinics can perform more high-value treatments in less time without the need for capital investments or hiring specialized personnel.
Positive Clinical Studies
OncoPatch Team
At OncoPatch, our mission is to provide an effective, non-invasive treatment for non-melanoma skin cancer using low-energy beta therapy. OncoPatch treatment offers an innovative solution that is more convenient for patients and may result in better cosmetic outcomes. Effective therapy can be delivered in a dermatologist’s office in as little as one treatment visit.
Our team of physicists, medical physicists, and material scientists are dedicated to improving the lives of skin cancer patients through innovation and discovery. We are actively working with various business partners to develop this treatment technology and make it available to patients suffering from non-melanoma skin cancer as soon as possible.
David Westerly, PhD
Co-founder & CEO
Quentin Diot, PhD
Co-founder
Frederic Sarazin, PhD
Co-founder
Jeramy Zimmerman, PhD
Co-founder
Investing In The Future Of Skin Cancer Treatment
With the incidence of skin cancer growing in the U.S., OncoPatch seeks to offer an effective, non-invasive treatment for non-melanoma skin cancers.
Multiple Funding Partners
OncoPatch research and development supported by:
- National Institutes of Health (NIH)
- Colorado Office of Economic Development and International Trade (CO-EDIT)
- CU Innovations
- Colorado School of Mines Foundation
- Cancer League of Colorado
- University of Colorado Cancer Center
Scalable Treatment Option
Easy market entry with no capital investments, specialized facilities, or additional personnel required. Providers will see increased revenues as physicians are able to deliver more high-value treatments in the same amount of time.
Large Market Opportunity
Non-melanoma skin cancer (NMSC) treatment represents a $4.8 billion market. There exists an unmet need for non-invasive, effective treatment options. OncoPatch is uniquely positioned to fulfill this need in a growing NMSC market.
Frequently Asked Questions
What is low-energy beta therapy?
Low-energy beta therapy is a special type of radiation therapy that uses low-energy electrons (i.e., beta particles) for treatment. Unlike X-ray or gamma-ray therapies, which use penetrating forms of radiation and require lead or concrete-shielded treatment rooms, the electrons emitted from low-energy beta sources can be stopped with less than a half-inch of plastic. When applied to a patient’s skin cancer, these electrons deposit the vast majority of their energy in the first few millimeters of tissue, focusing the therapeutic effect on the cancer and sparing the healthy tissue underneath. This allows for effective treatment to be delivered in as little as one session with minimal side effects.
Penetration difference between X-rays and low-energy beta particles used to treat non-melanoma skin cancer.
What types of skin cancer can OncoPatch treat?
Clinical investigations of OncoPatch are ongoing, however low-energy beta therapy has been used to successfully treat basal cell and squamous cell carcinomas.
How are the patches applied to the skin?
The OncoPatch applicator is attached to the skin using a gentle-release silicon bandage. This applicator allows the dermatologist to precisely define the position of the treatment patch while also ensuring the patch is securely held in place for the duration of the treatment.
How can I invest in OncoPatch?
OncoPatch is dedicated to improving the lives of skin cancer patients through innovation and discovery. If you share our passion and are interested in partnering with us, contact us via the link on this website and we will reach out to you shortly.
